Literature DB >> 9312103

Efficient mammalian protein synthesis requires an intact F-actin system.

R Stapulionis1, S Kolli, M P Deutscher.   

Abstract

The mammalian protein synthesizing system is highly organized in vivo, and its substrate, tRNA, is channeled throughout the translation process. However, the cellular components responsible for this organization are not known. To examine this question a series of studies was carried out using intact and permeabilized Chinese hamster ovary cells. We show that cold shock dramatically reduces the protein synthetic capacity of these cells by as much as 95%. The loss of activity can be reversed by a short recovery period under conditions that allow energy metabolism to occur; transcription and translation during the recovery period are not needed. While individual components of the translation apparatus are not inactivated by the cold shock, the supramolecular organization of the system appears to be altered and F-actin levels are found to decrease. Resumption of protein synthesis during the recovery period coincides closely with the restoration of F-actin to normal levels. Moreover, disruption of actin filaments, but not microtubules, also leads to a major reduction in translation. These data support the conclusion that the cellular microfilament network plays an important role in the structure and function of the translation system and that perturbations of this network can have profound effects on protein synthesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9312103     DOI: 10.1074/jbc.272.40.24980

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Nuclear actin is associated with a specific subset of hnRNP A/B-type proteins.

Authors:  Piergiorgio Percipalle; Andreas Jonsson; Dmitri Nashchekin; Christina Karlsson; Tomas Bergman; Apostolia Guialis; Bertil Daneholt
Journal:  Nucleic Acids Res       Date:  2002-04-15       Impact factor: 16.971

2.  Organization of mammalian cytoplasm.

Authors:  Alice Hudder; Lubov Nathanson; Murray P Deutscher
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

3.  Gene overexpression as a tool for identifying new trans-acting factors involved in translation termination in Saccharomyces cerevisiae.

Authors:  Olivier Namy; Isabelle Hatin; Guillaume Stahl; Hongmei Liu; Stephanie Barnay; Laure Bidou; Jean-Pierre Rousset
Journal:  Genetics       Date:  2002-06       Impact factor: 4.562

4.  Splicing enhances translation in mammalian cells: an additional function of the exon junction complex.

Authors:  Ajit Nott; Hervé Le Hir; Melissa J Moore
Journal:  Genes Dev       Date:  2004-01-15       Impact factor: 11.361

5.  Nuclear protein synthesis: a re-evaluation.

Authors:  Lubov Nathanson; Tianli Xia; Murray P Deutscher
Journal:  RNA       Date:  2003-01       Impact factor: 4.942

Review 6.  eEF1A: thinking outside the ribosome.

Authors:  Maria K Mateyak; Terri Goss Kinzy
Journal:  J Biol Chem       Date:  2010-05-05       Impact factor: 5.157

7.  Transcriptome and proteome profiling to understanding the biology of high productivity CHO cells.

Authors:  Peter Morin Nissom; Arleen Sanny; Yee Jiun Kok; Yeo Thong Hiang; Song Hui Chuah; Tan Kher Shing; Yih Yean Lee; Kathy Tin Kam Wong; Wei-Shou Hu; Miranda Yap Gek Sim; Robin Philp
Journal:  Mol Biotechnol       Date:  2006-10       Impact factor: 2.695

Review 8.  The long journey of actin and actin-associated proteins from genes to polysomes.

Authors:  Piergiorgio Percipalle
Journal:  Cell Mol Life Sci       Date:  2009-03-20       Impact factor: 9.261

9.  Proteomic profiling of recombinant cells from large-scale mammalian cell culture processes.

Authors:  Paula Meleady
Journal:  Cytotechnology       Date:  2007-02-24       Impact factor: 2.058

10.  A Legionella effector modulates host cytoskeletal structure by inhibiting actin polymerization.

Authors:  Zhenhua Guo; Robert Stephenson; Jiazhang Qiu; Shijun Zheng; Zhao-Qing Luo
Journal:  Microbes Infect       Date:  2013-11-26       Impact factor: 2.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.